⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MiraxBioPharma (MB Pharma) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MiraxBioPharma (MB Pharma)
↗Khimki, Russia
MiraxBioPharma is a fast-growing Russian full-cycle pharmaceutical company founded in 2005. The company specializes in the research, development, and production of innovative pharmaceutical products, medicinal substances, dietary supplements, and cosmetics, operating in compliance with GMP, GCP, GLP, and ISO standards.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Full-cycle Pharmaceutical Manufacturing
SIZE & FINANCIALS
Employees:51-200
Founded:2005
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Not specified - CEO
LINKS
Website:mbpharma.ru
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MiraxBioPharma (MB Pharma). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.